Proteomics reveals novel oxidative and glycolytic mechanisms in type 1 diabetic patients' skin which are normalized by kidney-pancreas transplantation

PLoS ONE

Volumn 5, Issue 3, 2010, Pages

  Folli, Franco ^a   Guzzi, Valeria ^b   Perego, Lucia ^b   Coletta, Dawn K ^c   Finzi, Giovanna ^d   Placidi, Claudia ^d   la Rosa, Stefano ^d   Capella, Carlo ^d   Socci, Carlo ^e   Lauro, Davide ^f   Tripathy, Devjit ^a   Jenkinson, Christopher ^a   Paroni, Rita ^b   Orsenigo, Elena ^e   Cighetti, Giuliana ^f   Gregorini, Luisa ^b   Staudacher, Carlo ^e   Secchi, Antonio ^e   Bachi, Angela ^g   Brownlee, Michael ^h   Fiorina, Paolo ⁱ   more..

^a UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

^b UNIVERSITY OF MILAN   (Italy)

^c ARIZONA STATE UNIVERSITY   (United States)

^d UNIVERSITY OF INSUBRIA   (Italy)

^e SAN RAFFAELE HOSPITAL   (Italy)

^f UNIVERSITY OF MILAN   (Italy)

^g VITA SALUTE SAN RAFFAELE UNIVERSITY   (Italy)

^h ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

ⁱ BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

OXYGEN;

ADULT; ARTICLE; CASE CONTROL STUDY; CHEMISTRY; CHRONIC KIDNEY FAILURE; FEMALE; GENE EXPRESSION REGULATION; GLYCOLYSIS; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; KIDNEY TRANSPLANTATION; MALE; MASS SPECTROMETRY; METABOLISM; METHODOLOGY; MIDDLE AGED; PANCREAS TRANSPLANTATION; PROTEOMICS; SKIN;

ADULT; CASE-CONTROL STUDIES; DIABETES MELLITUS, TYPE 1; FEMALE; GENE EXPRESSION REGULATION; GLYCOLYSIS; HUMANS; KIDNEY FAILURE, CHRONIC; KIDNEY TRANSPLANTATION; MALE; MIDDLE AGED; OXYGEN; PANCREAS TRANSPLANTATION; PROTEOMICS; SKIN; SPECTROMETRY, MASS, MATRIX-ASSISTED LASER DESORPTION-IONIZATION;

EID: 78649454844     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0009923     Document Type: Article

References (42)

1. Brownlee M (2003) A radical explanation for glucose-induced beta cell dysfunction. J Clin Invest 112: 1788-1790.
2. Brownlee M (2001) Biochemistry and molecular cell biology of diabetic complications. Nature 414: 813-820.
3. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. The Diabetes Control and Complications Trial Research Group. N Engl J Med 329: 977-986 (1993).
4. Nathan DM, Lachin J, Cleary P, Orchard T, Brillon DJ, et al. (2003) Intensive diabetes therapy and carotid intima-media thickness in type 1 diabetes mellitus. N Engl J Med 348: 2294-2303.
5. Vlassara H, Fuh H, Makita Z, Krungkrai S, Cerami A, et al. (1992) Exogenous advanced glycosylation end products induce complex vascular dysfunction in normal animals: a model for diabetic and aging complications. Proc Natl Acad Sci U S A 89: 12043-12047.
6. Vlassara H, Palace MR (2003) Glycoxidation: the menace of diabetes and aging. Mt Sinai J Med 70: 232-241.
7. Nishikawa T, Edelstein D, Du XL, Yamagishi S, Matsumura T, et al. (2000) Normalizing mitochondrial superoxide production blocks three pathways of hyperglycaemic damage. Nature 404: 787-790.
8. Cumming RC, Andon NL, Haynes PA, Park M, Fischer WH, et al. (2004) Protein disulfide bond formation in the cytoplasm during oxidative stress. J Biol Chem 279: 21749-21758.
9. Sutherland DE, Gruessner RW, Dunn DL, Matas AJ, Humar A, et al. (2001) Lessons learned from more than 1,000 pancreas transplants at a single institution. Ann Surg 233: 463-501.
10. La Rocca E, Fiorina P, di Carlo V, Astorri E, Rossetti C, et al. (2001) Cardiovascular outcomes after kidney-pancreas and kidney-alone transplantation. Kidney Int 60: 1964-1971.
11. La Rocca E, Fiorina P, Astorri E, Rossetti C, Lucignani G, et al. (2000) Patient survival and cardiovascular events after kidney-pancreas transplantation: comparison with kidney transplantation alone in uremic IDDM patients. Cell Transplant 9: 929-932.
12. Pascual M, Theruvath T, Kawai T, Tolkoff-Rubin N, Cosimi AB (2002) Strategies to improve long-term outcomes after renal transplantation. N Engl J Med 346: 580-590.
13. Wolfe RA, Ashby VB, Milford EL, Ojo AO, Ettenger RE, et al. (1999)Comparison of mortality in all patients on dialysis, patients on dialysis awaiting transplantation, and recipients of a first cadaveric transplant. N Engl J Med 341: 1725-1730.
14. Fiorina P, Folli F, Maffi P, Placidi C, Venturini M, et al. (2003) Islet transplantation improves vascular diabetic complications in patients with diabetes who underwent kidney transplantation: a comparison between kidney-pancreas and kidney-alone transplantation. Transplantation 75: 1296-1301.
15. Zhang W, Chait BT (2000) ProFound: an expert system for protein identification using mass spectrometric peptide mapping information. Anal Chem 72: 2482-2489.
16. Macaulay IC, Carr P, Gusnanto A, Ouwehand WH, Fitzgerald D, et al. (2005) Platelet genomics and proteomics in human health and disease. J Clin Invest 115: 3370-3377.
17. Vidal BC, Bonventre JV, S IHH (2005) Towards the application of proteomics in renal disease diagnosis. Clin Sci (Lond) 109: 421-430.
18. Iori E, Millioni R, Puricelli L, Arrigoni G, Lenzini L, et al. (2008) Glycolytic enzyme expression and pyruvate kinase activity in cultured fibroblasts from type 1 diabetic patients with and without nephropathy. Biochim Biophys Acta 1782: 627-633.
19. Tessari P, Puricelli L, Iori E, Arrigoni G, Vedovato M, et al. (2007) Altered chaperone and protein turnover regulators expression in cultured skin fibroblasts from type 1 diabetes mellitus with nephropathy. J Proteome Res 6: 976-986.
20. Fiorina P, Folli F, Bertuzzi F, Maffi P, Finzi G, et al. (2003) Long-term beneficial effect of islet transplantation on diabetic macro-/microangiopathy in type 1 diabetic kidney-transplanted patients. Diabetes Care 26: 1129-1136.
21. Properzi G, Terenghi G, Gu XH, Poccia G, Pasqua R, et al. (1995) Early increase precedes a depletion of endothelin-1 but not of von Willebrand factor in cutaneous microvessels of diabetic patients. A quantitative immunohistochemical study. J Pathol 175: 243-252.
22. Mortz E, Krogh TN, Vorum H, Gorg A (2001) Improved silver staining protocols for high sensitivity protein identification using matrix-assisted laser desorption/ionization-time of flight analysis. Proteomics 1: 1359-1363.
23. Hochstrasser DF, Harrington MG, Hochstrasser AC, Miller MJ, Merril CR (1988) Methods for increasing the resolution of two-dimensional protein electrophoresis. Anal Biochem 173: 424-435.
24. Shevchenko A, Wilm M, Vorm O, Mann M (1996) Mass spectrometric sequencing of proteins silver-stained polyacrylamide gels. Anal Chem 68: 850-858.
25. Oliveira HR, Curi R, Carpinelli AR (1999) Glucose induces an acute increase of superoxide dismutase activity in incubated rat pancreatic islets. Am J Physiol 276: C507-510.
26. Gruden G, Bruno G, Chaturvedi N, Burt D, Schalkwijk C, et al. (2008) Serum heat shock protein 27 and diabetes complications in the EURODIAB prospective complications study: a novel circulating marker for diabetic neuropathy. Diabetes 57: 1966-1970.
27. Schalkwijk CG, van Bezu J, van der Schors RC, Uchida K, Stehouwer CD, et al. (2006) Heat-shock protein 27 is a major methylglyoxal-modified protein in endothelial cells. FEBS Lett 580: 1565-1570.
28. Gulden E, Mollerus S, Bruggemann J, Burkart V, Habich C (2008) Heat shock protein 60 induces inflammatory mediators in mouse adipocytes. FEBS Lett 582: 2731-2736.
29. Quintana FJ, Cohen IR (2008) HSP60 speaks to the immune system in many voices. Novartis Found Symp 291: 101-111; discussion 111-104, 137-140.
30. Wolff SP, Dean RT (1987) Glucose autoxidation and protein modification. The potential role of 'autoxidative glycosylation' in diabetes. Biochem J 245: 243-250.
31. Hunt JV, Dean RT, Wolff SP (1988) Hydroxyl radical production and autoxidative glycosylation. Glucose autoxidation as the cause of protein damage in the experimental glycation model of diabetes mellitus and ageing. Biochem J 256: 205-212.
32. Fiorina P, La Rocca E, Venturini M, Minicucci F, Fermo I, et al. (2001) Effects of kidney-pancreas transplantation on atherosclerotic risk factors and endothelial function in patients with uremia and type 1 diabetes. Diabetes 50: 496-501.
33. Lee JP, Palfrey HC, Bindokas VP, Ghadge GD, Ma L, et al. (1999) The role of immunophilins in mutant superoxide dismutase-1linked familial amyotrophic lateral sclerosis. Proc Natl Acad Sci U S A 96: 3251-3256.
34. Cighetti G, Fermo I, Aman CS, Ferraroni M, Secchi A, et al. (2009) Dimethylarginines in complicated type 1 diabetes: roles of insulin, glucose, and oxidative stress. Free Radic Biol Med 47: 307-311.
35. Busik JV, Mohr S, Grant MB (2008) Hyperglycemia-induced reactive oxygen species toxicity to endothelial cells is dependent on paracrine mediators. Diabetes 57: 1952-1965.
36. Fiorina P, Folli F, D'Angelo A, Finzi G, Pellegatta F, et al. (2004) Normalization of multiple hemostatic abnormalities in uremic type 1 diabetic patients after kidney-pancreas transplantation. Diabetes 53: 2291-2300.
37. Von Harsdorf R, Li PF, Dietz R (1999) Signaling pathways in reactive oxygen species-induced cardiomyocyte apoptosis. Circulation 99: 2934-2941.
38. Tanaka Y, Gleason CE, Tran PO, Harmon JS, Robertson RP (1999) Prevention of glucose toxicity in HIT-T15 cells and Zucker diabetic fatty rats by antioxidants. Proc Natl Acad Sci U S A 96: 10857-10862.
39. Kiritoshi S, Nishikawa T, Sonoda K, Kukidome D, Senokuchi T, et al. (2003) Reactive oxygen species from mitochondria induce cyclooxygenase-2 gene expression in human mesangial cells: potential role in diabetic nephropathy. Diabetes 52: 2570-2577.
40. Makita Z, Radoff S, Rayfield EJ, Yang Z, Skolnik E, et al. (1991) Advanced glycosylation end products in patients with diabetic nephropathy. N Engl J Med 325: 836-842.
41. Ceriello A (2003) New insights on oxidative stress and diabetic complications may lead to a "causal" antioxidant therapy. Diabetes Care 26: 1589-1596.
42. Eberl N, Piehlmeier W, Dachauer S, Konig A, Land W, et al. (2005) Blood flow in the skin of type 1 diabetic patients before and after combined pancreas/ kidney transplantation. Diabetes Metab Res Rev 21: 525-532.